vitreous degeneration

Also found in: Dictionary, Thesaurus, Encyclopedia.


(de-jen?e-ra'shon) [ de- + generation]
Deterioration or impairment of an organ or part in the structure of cells and the substances of which they are a component. See: regenerationdegenerative (de-jen'e-rat?iv, -jen'e-ra-tiv), adjective

age-related macular degeneration

See: macular degeneration

amyloid degeneration

Degeneration of organs or tissues from amyloid deposits. The deposits are waxy and translucent and have a hyaline appearance. The liver, spleen, and kidneys are usually involved, but any tissue may be infiltrated.

ascending degeneration

Nerve fiber degeneration progressing to the center from the periphery.

calcareous degeneration

Infiltration of inorganic calcium into tissues.

caseous degeneration

Cheesy alteration of tissues, as seen in tuberculosis.

cloudy swelling degeneration

A condition in which protein in cells forms minute visible droplets The droplets give the cells a cloudy appearance and may occur in any inflamed tissue.

colloid degeneration

Mucoid degeneration in the protoplasm of epithelial cells.

congenital macular degeneration

Congenital degeneration of the macula of the eye.

corticobasal degeneration

A neurological disorder in which brain cells atrophy and die in the basal ganglia and the cortex of the brain. The disease produces symptoms similar to those found in Parkinson's disease but does not respond to parkinsonian medications.

cystic degeneration

Cyst formation accompanying degeneration.

descending degeneration

Nerve fiber degeneration progressing toward the periphery from the original lesion.

fatty degeneration

Deposit of abnormal amounts of fat in the cytoplasm of cells, or replacement or infiltration of tissues by fat cells.

fatty degeneration of the heart

Fatty infiltration of the heart.

fibroid degeneration

Change of membranous tissue into fibrous tissue.

frontotemporal lobar degeneration

Pick's disease.

granulovacuolar degeneration

A pathological finding in the brain cells of some patients with Alzheimer's dementia in which the neuronal cytoplasm is partly replaced by cavities that contain particles resembling grit or sand.

gray degeneration

Degeneration in myelinated nerve tissue due to chronic inflammation, causing the nerve tissue to turn gray.

hepatocerebral degeneration

Loss of nerve and supporting cells of the brain from multiple episodes of hepatic encephalopathy or coma. This condition may be caused by Wilson's disease or other insults to the liver, e.g., hepatic coma produced by alcoholic, drug-induced, or viral hepatitis.

hepatolenticular degeneration

Wilson's disease.

hyaline degeneration

A form of degeneration in which the tissues assume a homogeneous, glassy appearance. It is caused by hyaline deposits replacing musculoelastic elements of blood vessels with a firm, transparent substance that causes loss of elasticity. It is responsible for hardening of the arteries and is often followed by calcification or deposit of lime salts in dead tissue. Calcification also may result in concretions.
Synonym: vitreous degeneration; Zenker's degeneration

hydropic degeneration

Pathological change in cells marked by the appearance of water droplets in the cytoplasm.

lattice degeneration

Atrophy or thinning of the retina at its margins, a common condition that affects about 10% of the population. The condition is usually bilateral and is often asymptomatic although affected persons may complain of seeing sudden flashes of light. It is an occasional cause of retinal detachment.

lipoidal degeneration

Deposition of fat droplets in cells.

macular degeneration

, age-related macular degeneration Abbreviation: MD
Loss of pigmentation in the macular region of the retina, usually affecting those over 50. It is a common disease of unknown cause that produces central visual field loss and is the leading cause of permanent visual impairment in the U.S. By age 75, about 15% of Americans are affected. Contributing factors to this disease include a family history of age-related macular degeneration, advancing age, cataract surgery, hyperlipidemia, hypertension, obesity, smoking, and a diet low in carotenoids, vitamin C, vitamin E, and zinc. Persons with Alzheimer's Disease will eventually develop MD but the reverse is not true


There are two kinds of macular degeneration: wet and dry. In wet MD, neovascularization intrudes under the retinal pigment epithelium from the choroid, where the new blood vessels may suddenly bleed or leak fluid, distort the normal architecture of the macula, and degrade central visual acuity. The visual loss caused by wet MD is an emergency. In dry MD, the more common and more benign form, hard and soft drusen accumulate beneath the retinal pigment epithelium. They may cause slowly progressive blurring of central vision or may occasionally and gradually lead to wet MD.

The central visual loss that marks macular degeneration can make reading, working with the hands, driving, or recognizing people's faces difficult because the center of the visual field is the region of greatest loss of visual acuity (i.e., a central scotoma). Peripheral vision is preserved in this disease. See: visual field for illus


Laser photocoagulation of new blood vessel membranes can help arrest visual loss in some patients with the exudative form of age-related macular degeneration, changing the wet form to the dry form. However, this form of treatment is complicated by a high rate of recurrence and some immediate visual loss in a scotoma. Other treatments include antiangiogenic drugs, regimens with Vitamins A, C, E, and zinc and copper, photodynamic therapy, radiation therapy, and retinal surgery.

Patient care

The Amsler grid, and other testing devices such as a tangent screen, can be used to test patients for visual distortions due to retinal disease, but the validity and reproducibility of Amsler grid testing is poor. Low vision optical aids improve the quality of life for patients who retain good peripheral vision. Affected patients should be referred for visual rehabilitation.

mucoid degeneration

Mucous degeneration.

mucous degeneration

Deposition of mucus in the connective tissue of organs or in epithelial cells.
Synonym: mucoid degeneration; myxomatous degeneration

myxomatous degeneration

Mucoid degeneration.

Nissl degeneration

See: Nissl, Franz

pigmentary degeneration

Degeneration in which affected cells develop an abnormal color.

polypoid degeneration

Formation of polyp-like growths on mucous membranes.

secondary degeneration

Wallerian degeneration.

senile degeneration

The bodily and mental changes that occur during pathological aging.

spongy degeneration

Familial demyelination of the deep layers of the cerebral cortex. The affected area has a spongy appearance. Symptoms include mental retardation, enlarged head, muscular flaccidity, and blindness. Death usually occurs before 18 months of age.

subacute combined degeneration of spinal cord

Degeneration of the posterior and lateral columns of the spinal column. Clinically, paresthesia, sensory ataxia, and sometimes spastic paraplegia are present. The disease is the result of pernicious anemia.

vacuolar degeneration

Swelling of cells with an increase in the number and size of vacuoles. Synonym: cloudy swelling

vitelliform degeneration

Best's disease.

vitreous degeneration

Hyaline degeneration.

wallerian degeneration

The dying back of the axons of nerves after an insult to nerve tissue, such as a toxic exposure, a metabolic change, trauma, or deprivation of blood supply. The myelin surrounding the axon deteriorates, and the ability of the axon to transmit signals diminishes.
Synonym: secondary degeneration

waxy degeneration

Amyloid degeneration seen in wasting diseases.

Zenker degeneration

See: Zenker, Friedrich Albert von
Medical Dictionary, © 2009 Farlex and Partners
References in periodicals archive ?
In this study, we assessed the stages of vitreous degeneration in patients with VMT and MH.
As demonstrated in this study, vitreous degeneration is variable.
Mean peak to peak amplitudes seemed to be smaller for each dogs with b/a ratio higher than the normal range; 3.74+0.97 for dog with mature cataract and 5.40+2.72 for dog with hypermature cataract and vitreous degeneration indicating affection of outer retinal layers.